Abstract Background The 2010 International Consensus Algorithm for the Diagnosis,
Therapy and Management of Hereditary Angioedema was published earlier this year in this …

Abstract Background We published the Canadian 2003 International Consensus Algorithm
for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor …

The 2010 International Consensus Algorithm for the Diagnosis, Therapy and Management
of Hereditary Angioedema was arrived at during the Canadian Hereditary Angioedema …

Background: Hereditary angioedema is an autosomal dominant disease that presents with
recurrent episodic swelling of the submucosal and/or subcutaneous tissues of the …

Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and
appropriate therapy are often unknown or not available for physicians and other health care …

This is an update to the 2014 Canadian Hereditary Angioedema Guideline with an
expanded scope to include the management of hereditary angioedema (HAE) patients …

The aim of treatment of hereditary angioedema (HAE) due to C1 esterase inhibitor
deficiency (HAE-C1-INH) is either treating acute attacks or preventing attacks by using …

OBJECTIVE: To provide a context to understand the opportunity for novel therapeutic
modalities to transform the treatment of hereditary angioedema (HAE). DATA SOURCES …

Background Hereditary angioedema (HAE) is a rare, life-threatening genetic disorder
characterized by recurrent episodes of subcutaneous or submucosal angioedema. The …

Hereditary angioedema (HAE) is an autosomal dominant disease characterized by recurrent
episodes of edema involving the skin, gastrointestinal tract, and/or airway. With a prevalence …